229.02 - 234.51
169.21 - 260.10
55.82M / 54.92M (Avg.)
32.24 | 7.26
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-18.99%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-20.34%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-26.73%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-26.73%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-27.73%
Both companies face declining net income. Martin Whitman would suspect external pressures or flawed business models in the space.
-25.00%
Negative EPS growth while VUZI is at 44.68%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-25.00%
Negative diluted EPS growth while VUZI is at 44.68%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-2.24%
Share reduction while VUZI is at 104.02%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-2.30%
Reduced diluted shares while VUZI is at 103.33%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
15.43%
Dividend growth of 15.43% while VUZI is flat. Bruce Berkowitz would see if this can become a bigger advantage long term.
-37.40%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-43.05%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
1695.90%
Positive 10Y revenue/share CAGR while VUZI is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
355.28%
Positive 5Y CAGR while VUZI is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
123.41%
Positive 3Y CAGR while VUZI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
76762.41%
10Y OCF/share CAGR above 1.5x VUZI's 51.66%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
470.08%
5Y OCF/share CAGR above 1.5x VUZI's 51.66%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
61.91%
Positive 3Y OCF/share CAGR while VUZI is negative. John Neff might see a big short-term edge in operational efficiency.
28426.51%
Net income/share CAGR above 1.5x VUZI's 42.88% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
519.22%
5Y net income/share CAGR above 1.5x VUZI's 42.88%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
110.63%
3Y net income/share CAGR above 1.5x VUZI's 23.56%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
2208.15%
Positive growth while VUZI is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
504.78%
Positive 5Y equity/share CAGR while VUZI is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
184.13%
3Y equity/share CAGR above 1.5x VUZI's 7.39%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
24.77%
Our AR growth while VUZI is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
36.31%
Inventory growth well above VUZI's 9.48%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
2.63%
Asset growth well under 50% of VUZI's 81.48%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-6.87%
We have a declining book value while VUZI shows 54.94%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
No Data
No Data available this quarter, please select a different quarter.
5.27%
R&D dropping or stable vs. VUZI's 11.70%. David Dodd sees near-term margin benefits if the product pipeline is already strong.
-1.01%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.
